These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 3034649

  • 21. Pharmacodynamic aspects of aclarubicin with special reference to daunorubicin and doxorubicin.
    Skovsgaard T.
    Eur J Haematol Suppl; 1987; 47():7-20. PubMed ID: 3552720
    [No Abstract] [Full Text] [Related]

  • 22. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
    Marzin D, Jasmin C, Maral R, Mathe G.
    Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
    [Abstract] [Full Text] [Related]

  • 23. Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3.
    Hofman J, Malcekova B, Skarka A, Novotna E, Wsol V.
    Toxicol Appl Pharmacol; 2014 Aug 01; 278(3):238-48. PubMed ID: 24832494
    [Abstract] [Full Text] [Related]

  • 24. Effect of structural modifications of anthracyclines on the ability to overcome drug resistance of cancer cells.
    Wasowska M, Wietrzyk J, Opolski A, Oszczapowicz J, Oszczapowicz I.
    Anticancer Res; 2006 Aug 01; 26(3A):2009-12. PubMed ID: 16827137
    [Abstract] [Full Text] [Related]

  • 25. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents.
    Schwartz HS, Kanter PM.
    Cancer Treat Rep; 1979 May 01; 63(5):821-5. PubMed ID: 287555
    [Abstract] [Full Text] [Related]

  • 26. Interaction of aclarubicin with DNA as compared with daunorubicin and doxorubicin.
    Ando S, Sasada M, Uchino H, Kagawa D, Ueda T, Nakamura T.
    Nihon Gan Chiryo Gakkai Shi; 1986 Dec 20; 21(10):2343-55. PubMed ID: 3471823
    [No Abstract] [Full Text] [Related]

  • 27. Reversal of acquired resistance to vinca alkaloids and anthracycline antibiotics.
    Tsuruo T.
    Cancer Treat Rep; 1983 Oct 20; 67(10):889-94. PubMed ID: 6354436
    [Abstract] [Full Text] [Related]

  • 28. Failure of aclacinomycin and 7-con-O-methylnogarol (7-OMEN) to decrease cardiac guanylate cyclase activity.
    Levey BA, Ruiz E, Rogerson B, Lehotay DC, Levey GS.
    Cancer Treat Rep; 1980 Oct 20; 64(10-11):1127-8. PubMed ID: 6109566
    [No Abstract] [Full Text] [Related]

  • 29. Phase I and II agents in cancer therapy: I. Anthracyclines and related compounds.
    Wadler S, Fuks JZ, Wiernik PH.
    J Clin Pharmacol; 1986 Oct 20; 26(7):491-509. PubMed ID: 2944917
    [Abstract] [Full Text] [Related]

  • 30. Epidoxoform: a hydrolytically more stable anthracycline-formaldehyde conjugate toxic to resistant tumor cells.
    Taatjes DJ, Fenick DJ, Koch TH.
    J Med Chem; 1998 Apr 09; 41(8):1306-14. PubMed ID: 9548820
    [Abstract] [Full Text] [Related]

  • 31. [In vitro drug-sensitivity test using human tumor clonogenic assay in lung cancer patients].
    Ohnoshi T, Hiraki S.
    Gan To Kagaku Ryoho; 1985 Aug 09; 12(8):1582-7. PubMed ID: 3927847
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells.
    Babudri N, Pani B, Tamaro M, Monti-Bragadin C, Zunino F.
    Br J Cancer; 1984 Jul 09; 50(1):91-6. PubMed ID: 6378238
    [Abstract] [Full Text] [Related]

  • 37. The anthracycline antineoplastic drugs.
    Young RC, Ozols RF, Myers CE.
    N Engl J Med; 1981 Jul 16; 305(3):139-53. PubMed ID: 7017406
    [No Abstract] [Full Text] [Related]

  • 38. Effects of tunicamycin on anthracycline resistance in P388 murine leukemia cells.
    Chou TH, Kessel D.
    Biochem Pharmacol; 1981 Nov 15; 30(22):3134-6. PubMed ID: 6950722
    [No Abstract] [Full Text] [Related]

  • 39. [Models of preclinical studies of anthracyclines].
    Fizames C.
    Pathol Biol (Paris); 1987 Jan 15; 35(1):41-8. PubMed ID: 3550611
    [Abstract] [Full Text] [Related]

  • 40. Daunorubicin-resistant Chinese hamster ovary cells expressing multidrug resistance and a cell-surface P-glycoprotein.
    Kartner N, Shales M, Riordan JR, Ling V.
    Cancer Res; 1983 Sep 15; 43(9):4413-9. PubMed ID: 6135505
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.